Cost Of Revenue - Genfit SA (NASDAQ:GNFT) - Alpha Spread

Genfit SA
NASDAQ:GNFT

Watchlist Manager
Genfit SA Logo
Genfit SA
NASDAQ:GNFT
Watchlist
Price: 4.19 USD -3.46% Market Closed
Market Cap: 209.5m USD
Have any thoughts about
Genfit SA?
Write Note

Genfit SA
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Genfit SA
Cost of Revenue Peer Comparison

Comparables:
VLA
NANO
IPH
ALERS
OSE

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Genfit SA
NASDAQ:GNFT
Cost of Revenue
-€2.2m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Valneva SE
PAR:VLA
Cost of Revenue
-€135.8m
CAGR 3-Years
-26%
CAGR 5-Years
-26%
CAGR 10-Years
-23%
Nanobiotix SA
PAR:NANO
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Cost of Revenue
-€3m
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
14%
Eurobio Scientific SA
PAR:ALERS
Cost of Revenue
-€68.8m
CAGR 3-Years
4%
CAGR 5-Years
-16%
CAGR 10-Years
-16%
OSE Immunotherapeutics SA
PAR:OSE
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Genfit SA's Cost of Revenue?
Cost of Revenue
-2.2m EUR

Based on the financial report for Dec 31, 2023, Genfit SA's Cost of Revenue amounts to -2.2m EUR.

What is Genfit SA's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%

Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Genfit SA have been -1% over the past three years , -3% over the past five years , and -5% over the past ten years .

Back to Top